Why the ‘molecular scissors’ metaphor for understanding CRISPR is misleading
By Naomi Schalit,
The Conversation
| 07. 04. 2019
Last week I read an article about CRISPR, the latest tool scientists are using to edit DNA. It was a great piece – well researched, beautifully written, factually accurate. It covered some of the amazing projects scientist are working on using CRISPR, like bringing animals back from extinction and curing diseases. It also gave me the heebies, but not for the reason you might expect.
My unease was the echo of a feeling I’d had during the early days of my PhD, when some fellow malaria researchers made a discovery that was reported on the news. I was thrilled for them, but I understood the incremental nature of the work they were doing. I knew that in a real-world, drugs-in-the-clinic sense, we were no closer to a breakthrough than we’d been the day before. I thought the reporters had communicated that clearly. Five minutes later my Dad called to ask if I was out of a job, and what I was going to do now that malaria was cured.
I don’t pretend to understand all the myriad reasons for the...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...